Examination Report |
1 | TM-A(TRADE MARKS APPLICATION) | 19 Mar 2020 |
2 | Reply to Exam Report (MIS-R) | 21 Jul 2020 |
3 | Documents in support of Show cause Hearing (SCH) | 20 Sep 2021 |
4 | Journal Copy | 17 Nov 2021 |
5 | TM-O(NOTICE OF OPPOSITION) | 04 Feb 2022 |
6 | TM-O(NOTICE OF OPPOSITION) | 20 Apr 2022 |
7 | Note Sheet | 20 Apr 2022 |
1 | EXAMINATION REPORT | 10096676 | 24 Jun 2020 | |
2 | Hearing Notice (Show Cause) | 11912214 | 30 Jul 2021 | |
3 | Tribunal Accepted Notice for : 4477249 | 12179333 | 5314317 | 20 Sep 2021 |
4 | Opposition Notice | 13116266 | 5523842 | 03 Mar 2022 |
5 | Opposition Notice | 13637430 | 5629897 | 13 Jun 2022 |
6 | Opposition Counter Statement | 14388557 | 5775095 | 24 Nov 2022 |
The application for Pregaba-d was made on 19 March 2020.
The trademark applicant for Pregaba-d is TORRENT PHARMACEUTICALS.
Pregaba-d is applied in class(es) 5.
Application for Pregaba-d is on Opposed stage.
Application Id allotted to Pregaba-d is 4477249.
Trademark agent or attorney for the application is R. R. Shah & Co.
Pregaba-d filed with the Intellectual property office as a WORD.